Wistar scientists develop new bispecific T cell engager to target ovarian cancer
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
Common heart risk calculators effectively predict certain types of cancer
Risk calculators that doctors use to estimate a person’s risk of a heart attack or stroke work about…
Study examines the link between blood type and cardiovascular risk in hemodialysis patients
Do you know your blood type? It is important information that is used for blood transfusions, but few…
Study tests chronotype’s liver link and finds no significant association
A small Italian study tested whether an individual’s preferred daily schedule aligns with hidden liver changes, but found…
Oral drug avatrombopag reduces chemotherapy treatment delays, trial finds
In a phase 2 trial of patients with gastrointestinal cancers, avatrombopag helped 70% of those receiving chemotherapy to…
Fish oil supplementation during pregnancy changes two childhood brain metabolic markers
A decade after mothers received EPA- and DHA-rich fish oil, MRI scans revealed subtle metabolic differences in their…
New study redefines high risk criteria for multiple myeloma
Researchers have found that with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should…
Long-term study shows how neighborhood conditions shape women’s heart health
Women who live in disadvantaged neighborhoods face worse heart health and experience faster decline as they approach menopause,…
New ctDNA blood test improves personalized prostate cancer treatment
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to…
A breakthrough in coronary bypass surgery: AMT Medical’s SAFE-CAB results published in The Journal of Thoracic and Cardiovascular Surgery
AMT Medical B.V., a clinical-stage Dutch medical technology company, today announced that the one-year results of the SAFE-CAB…
Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge
A six-cohort analysis links higher baseline p-tau217 to rising 5- and 10-year risks, bringing presymptomatic risk models closer…
New guideline offers recommendations for testosterone replacement therapy use
The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing…